{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:01Z","timestamp":1761514381136,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.yebeh.2019.03.050","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T22:22:06Z","timestamp":1556058126000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The effect of fluoxetine on penicillin-induced epileptiform activity"],"prefix":"10.1016","volume":"95","author":[{"given":"Hatice","family":"Aygun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yebeh.2019.03.050_bb0005","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.brainresbull.2005.09.012","article-title":"The effect of leptin on penicillin-induced epileptiform activity in rats","volume":"68","author":"Ayyildiz","year":"2006","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0010","first-page":"1","article-title":"The effect of duloxetine on penicillin-induced epileptiform activity in rats","author":"Esen","year":"2018","journal-title":"Neurol Res"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0015","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.3390\/ijms140918284","article-title":"Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions","volume":"14","author":"Reddy","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12013-015-0603-y","article-title":"Recent advances in epilepsy management","volume":"73","author":"Huang","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1590\/S0004-282X2013000300011","article-title":"Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences","volume":"71","author":"Valente","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2019.03.050_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.2002.043s2002.x","article-title":"Basic mechanism of psychotropic drugs","volume":"43","author":"Ebert","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0035","first-page":"535","article-title":"Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues","volume":"11","author":"Magyar","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-3223(03)00469-4","article-title":"Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment","volume":"54","author":"Kanner","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1474-4422(12)70201-6","article-title":"Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders?","volume":"11","author":"Kanner","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.03.050_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: a bidirectional association","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1525-5069(02)00503-0","article-title":"Treatment of depressive disorders in epilepsy patients","volume":"3","author":"Gilliam","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yebeh.2003.08.019","article-title":"Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy","volume":"4","author":"Jones","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0065","first-page":"1","article-title":"Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations","author":"Garcia","year":"2012","journal-title":"Epilepsy Res Treat"},{"issue":"3","key":"10.1016\/j.yebeh.2019.03.050_bb0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neulet.2004.10.009","article-title":"The effect of fluoxetine in a model of chemically induced seizures\u2014behavioral and immunocytochemical study","volume":"373","author":"Zienowicz","year":"2005","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.yebeh.2019.03.050_bb0075","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/bph.12052","article-title":"Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?","volume":"168","author":"Cardamone","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.03.050_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1059-1311(05)80192-X","article-title":"Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy","volume":"3","author":"Gigli","year":"1994","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.yebeh.2019.03.050_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1059-1311(05)80148-7","article-title":"Seizures associated with fluoxetine therapy","volume":"2","author":"Prasher","year":"1993","journal-title":"Seizure"},{"issue":"10","key":"10.1016\/j.yebeh.2019.03.050_bb0090","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.45.10.1926","article-title":"Anticonvulsant effect of fluoxetine in humans","volume":"45","author":"Favale","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebcr.2014.03.001","article-title":"Seizure reduction with fluoxetine in Dravet syndrome","volume":"2","author":"Meador","year":"2014","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1528-1157.1993.tb02425.x","article-title":"Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats","volume":"34","author":"Prendiville","year":"1993","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2019.03.050_bb0105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1528-1157.2002.48701.x","article-title":"Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy","volume":"43","author":"Hernandez","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0091-3057(85)90067-X","article-title":"Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA\/2J mice","volume":"23","author":"Sparks","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2019.03.050_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0024-3205(95)02286-4","article-title":"Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)","volume":"58","author":"Dailey","year":"1996","journal-title":"Life Sci"},{"issue":"24","key":"10.1016\/j.yebeh.2019.03.050_bb0120","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/0024-3205(78)90297-7","article-title":"Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock","volume":"23","author":"Buterbaugh","year":"1978","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.yebeh.2019.03.050_bb0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/1871527315666160720121723","article-title":"Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats","volume":"16","author":"Shiha","year":"2017","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.yebeh.2019.03.050_bb0130","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0014-4886(03)00352-2","article-title":"5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike\u2013wave discharges in a genetic rat model of absence epilepsy","volume":"184","author":"Jakus","year":"2003","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.03.050_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2006.06.014","article-title":"Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus","volume":"408","author":"Freitas","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2013.11.020","article-title":"Chronic antidepressant treatment accelerates kindling epileptogenesis in rats","volume":"63","author":"Cardamone","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.yebeh.2019.03.050_bb0145","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/epi.14435","article-title":"Chronic fluoxetine treatment accelerates kindling epileptogenesis in mice independently of 5-HT 2A receptors","volume":"59","author":"Li","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbr.2019.01.060","article-title":"Swimming exercise decreases the absence-like epileptic activity in WAG\/Rij rats","volume":"363","author":"Aygun","year":"2019","journal-title":"Behav Brain Res"},{"issue":"18","key":"10.1016\/j.yebeh.2019.03.050_bb0155","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1097\/00001756-199412000-00012","article-title":"Evidence that sodium nitroprusside possesses anticonvulsant effects mediated through nitric oxide","volume":"5","author":"Marangoz","year":"1994","journal-title":"Neuroreport."},{"issue":"1","key":"10.1016\/j.yebeh.2019.03.050_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00221-006-0425-7","article-title":"The effects of vitamin E on penicillin-induced epileptiform activity in rats","volume":"174","author":"Ayyildiz","year":"2006","journal-title":"Exp Brain Res"},{"issue":"5","key":"10.1016\/j.yebeh.2019.03.050_bb0165","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yebeh.2007.01.004","article-title":"Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression","volume":"10","author":"Thom\u00e9-Souza","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainresbull.2014.12.009","article-title":"Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats","volume":"111","author":"Shiha","year":"2015","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0404.1992.tb04469.x","article-title":"Epileptogenesis: contributions of calcium ions and antiepileptic calcium antagonists","volume":"150","author":"Walden","year":"1992","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.yebeh.2019.03.050_bb0185","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0028-3908(99)00206-3","article-title":"Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells","volume":"39","author":"De\u00e1k","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2019.03.050_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.eplepsyres.2012.03.019","article-title":"The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events","volume":"101","author":"Igelstr\u00f6m","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1528-1157.1994.tb05955.x","article-title":"Mechanisms of action of currently prescribed and newly developed antiepileptic drugs","volume":"35","author":"MacDonald","year":"1994","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2019.03.050_bb0200","first-page":"49","article-title":"Block of T-type Ca2+ channels is an important action of succinimide antiabsence drugs","volume":"2","author":"Huguenard","year":"2004","journal-title":"Epilepsy Curr"},{"issue":"3","key":"10.1016\/j.yebeh.2019.03.050_bb0205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/neu.20107","article-title":"Differential expression of T-type calcium channel mutant mice with ataxia and absence epilepsy","volume":"62","author":"Nahm","year":"2005","journal-title":"J Neurobiol"},{"issue":"2","key":"10.1016\/j.yebeh.2019.03.050_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(96)00384-7","article-title":"A calcium antagonistic effect of the new antiepileptic drug lamotrigine","volume":"7","author":"von Wegerer","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2019.03.050_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2004.04.040","article-title":"Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents","volume":"127","author":"Curia","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2210-4-14","article-title":"A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats","volume":"4","author":"McClelland","year":"2004","journal-title":"BMC Pharmacol"},{"issue":"7","key":"10.1016\/j.yebeh.2019.03.050_bb0225","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0013-9580.2004.02204.x","article-title":"Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine","volume":"45","author":"Pisani","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0230","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0896-6273(91)90333-U","article-title":"Neuropeptides in perspective: the last ten years","volume":"7","author":"H\u00f6kfelt","year":"1991","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.yebeh.2019.03.050_bb0235","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.pnpbp.2005.04.013","article-title":"Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: correlation with the hippocampal glutamate release","volume":"29","author":"Ferrero","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.yebeh.2019.03.050_bb0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00004850-199300810-00004","article-title":"Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine","volume":"8","author":"Norman","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1254\/jphs.FP0070759","article-title":"Open channel block of Kv3.1 currents by fluoxetine","volume":"106","author":"Sung","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0250","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1152\/jn.1992.68.3.756","article-title":"Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain","volume":"68","author":"Perney","year":"1992","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0255","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1152\/jn.1999.82.5.2476","article-title":"Function of specific K+ channels in sustained high-frequency firing of fast-spiking neocortical interneurons","volume":"82","author":"Erisir","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(97)00527-1","article-title":"Subcellular localization of the K+ channel subunit Kv3.1b in selected rat CNS neurons","volume":"766","author":"Sekirnjak","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0265","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1749-6632.1999.tb11295.x","article-title":"Contributions of Kv3 channels to neuronal excitability","volume":"868","author":"Rudy","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0270","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/jn.2002.88.1.394","article-title":"Differential subcellular localization of the two alternatively spliced isoforms of the Kv3.1 potassium channel subunit in brain","volume":"88","author":"Ozaita","year":"2002","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.1016\/j.yebeh.2019.03.050_bb0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12272-015-0676-6","article-title":"Differential effects of sodium channel blockers on in vitro induced epileptiform activities","volume":"40","author":"G\u00e1ll","year":"2017","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.yebeh.2019.03.050_bb0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(02)02239-2","article-title":"Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs","volume":"452","author":"Nicholson","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"10.1016\/j.yebeh.2019.03.050_bb0285","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation","volume":"27","author":"Ogiwara","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1528-1157.1976.tb03396.x","article-title":"Biphasic effects of imipramine in experimental models of epilepsy","volume":"17","author":"Lange","year":"1976","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0295","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuint.2016.06.001","article-title":"Antidepressant drugs in convulsive seizures: pre-clinical evaluation of duloxetine in mice","volume":"99","author":"Santana-Coelho","year":"2016","journal-title":"Neurochem Int"},{"issue":"3","key":"10.1016\/j.yebeh.2019.03.050_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eplepsyres.2012.04.004","article-title":"5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide","volume":"101","author":"Payandemehr","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-8993(97)00366-1","article-title":"Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy","volume":"759","author":"Wada","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2019.03.050_bb0315","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019301015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019301015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:27:41Z","timestamp":1761503261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019301015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":63,"alternative-id":["S1525505019301015"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.050","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of fluoxetine on penicillin-induced epileptiform activity","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}